1395415-86-7

Upstream product

• 67-56-1 methanol 
• 201230-82-2 carbon monoxide 
• 1215205-96-1 1-bromo-3-(methylsulfonyl)-5-(trifluoromethyl)benzene 

Downstream Products

• 1395414-21-7 [[4-(2-fluoro-phenyl)-pyridin-3-yl]-(3-methanesulfonyl-5-trifluoromethyl-benzoyl)-amino]-acetic acid methyl ester 
• 1395414-22-8 N-[4-(2-fluoro-phenyl)-pyridin-3-yl]-3-methanesulfonyl-N-(2,2,2-trifluoro-ethyl)-5-trifluoromethyl-benzamide 
• 1395414-23-9 N-(2,2-difluoro-ethyl)-N-[4-(2-fluoro-phenyl)-pyridin-3-yl]-3-methanesulfonyl-5-trifluoromethyl-benzamide 
• 53985-43-6 3-methanesulfonyl-5-trifluoromethylbenzoic acid 
• 1395416-72-4 3-(methylsulfonyl)-5-(trifluoromethyl)benzoyl chloride 
• 1466573-99-8 N-[4-(4-fluoro-2-methoxyphenyl)pyridazin-3-yl]-3-methanesulfonyl-N-methyl-5-trifluoromethylbenzamide 
• 1466574-01-5 N-[4-(4-fluoro-2-methoxyphenyl)-6-methylpyridazin-3-yl]-3-methanesulfonyl-N-methyl-5-trifluoromethylbenzamide 
• 1466573-98-7 N-[6-chloro-4-(4-fluoro-2-methoxyphenyl)pyridazin-3-yl]-3-methanesulfonyl-N-methyl-5-trifluoromethyl benzamide 
• 1466574-13-9 N-[6-chloro-4-(2-methoxypyridin-3-yl)pyridazin-3-yl]-3-methanesulfonyl-N-methyl-5-trifluoromethylbenzamide 

Relevant academic research and scientific papers

1,2-PYRIDAZINES, 1,6-PYRIDAZINES AND PYRIMIDINES

This invention relates to novel 1,2-pyridazines, 1,6-pyridazines or pyrimidines of the formula wherein B1 to B3 and R1 to R7 are as defined in the description and in the claims, as well as pharmaceutically accep

1,2- PYRIDAZINE, 1,6- PYRIDAZINE OR PYRIMIDINE - BENZAMIDE DERIVATIVES AS GPBAR1 MODULATORS

This invention relates to novel 1,2-pyridazines, 1,6-pyridazines or pyrimidines of the formula I wherein B1 to B3 and R1 to R7 are as defined in the description and in the claims, as well as pharmaceutically acc

3-AMINO-PYRIDINES AS GPBAR1 AGONISTS

This invention relates to novel 3-aminopyridines of the formula wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes

3-AMINO-PYRIDINES AS GPBAR1 AGONISTS

This invention relates to novel 3-aminopyridines of the formula (I) wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.